Clinical Trial Update: Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel [Phase 2, Phase 3]

View source ↗

Summary

The Mirror Trial evaluating follow-up management of peripheral arterial intervention using clopidogrel in Phase 2/3 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Peripheral Vascular Diseases | Phase 2, Phase 3 | Status: COMPLETED